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Background: The link between type 2 diabetes and hypertension is well established and the conditions often
coexist. High normal blood pressure, defined by WHO-ISH as systolic blood pressure (SBP) 130–139 mm Hg or
diastolic blood pressure (DBP) 85–89 mm Hg, has been found to be an independent predictor for type 2 diabetes
in studies, although with relatively limited follow-up periods of approximately 10 years. The aim of this study was to
investigate whether hypertension, including mildly elevated blood pressure within the normal range, predicted
subsequent development of type 2 diabetes in men over an extended follow-up of 35 years.
Methods: Data were derived from the Gothenburg Primary Prevention Study where a random sample of 7 494
men aged 47–55 years underwent a baseline screening investigation in the period 1970–1973. A total of 7 333 men
were free from previous history of diabetes at baseline. During a 35-year follow-up diabetes was identified through
the Swedish hospital discharge and death registries. The cumulative risk of diabetes adjusted for age and
competing risk of death was calculated. Using Cox proportional hazard models we calculated the multiple adjusted
hazard ratios (HR) (95% confidence interval (CI)) for diabetes at different blood pressure levels.
Results: During a 35-year follow-up, 956 men (13%) were identified with diabetes. The 35-year cumulative risk of
diabetes after adjusting for age and competing risk of death in men with SBP levels <130 mm Hg, 130–139 mm
Hg, 140–159 mm Hg and ≥160 mm Hg were 19%, 30%, 31% and 49%, respectively. The HR for diabetes adjusted
for age, body mass index (BMI), cholesterol, antihypertensive treatment, smoking, physical activity and occupation
were 1.43 (95% CI 1.12-1.84), 1.43 (95% CI 1.14-1.79) and 1.95 (95% CI 1.55-2.46) for men with SBP 130–139 mm Hg,
140–159 mm Hg, and ≥ 160 mm Hg, respectively (reference; SBP<130 mm Hg).
Conclusion: In this population, at mid-life, even high-normal SBP levels were shown to be a significant predictor of
type 2 diabetes, independently of BMI and other conventional type 2 diabetes risk factors over an extended
follow-up.
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The incidence of type 2 diabetes is increasing rapidly
worldwide, due mainly to an aging population, rapid
increases in overweight and obesity, and population
growth [1-4]. Diabetes plays a significant role in cardio-
vascular morbidity and mortality, and therefore it is im-
portant to identify individuals at increased risk of
developing diabetes in order to introduce preventive
strategies [5]. Patients with type 2 diabetes often have
hypertension and other cardiovascular risk factors, in-
creasing the risk of cardiovascular morbidity still further
[6]. Previous studies have shown that hypertension is an
independent predictor of type 2 diabetes [7,8]. In recent
years, studies have indicated that blood pressure in
the upper normal range also predicts incident diabetes
[9-13]. If so, even persons with mildly raised blood pres-
sure might benefit from increased surveillance of glucose
levels and preventive strategies against type 2 diabetes.
The follow-up time in studies examining the relationship
between high normal blood pressure and diabetes is
often 10 years or less, whereas most cardiovascular dis-
ease (CVD) events occur late in life. A risk factor indi-
cating an increased risk of an outcome after 10 years is
not necessarily of importance in a longer follow-up
[14,15]. For example, we have shown that smoking, a
strong risk factor in midlife for coronary heart disease
(CHD), becomes less important over time and was no
longer a significant risk factor after 21 years [14]. Al-
though we know from the Framingham study that risk
factors in midlife are important for long-term outcomes
and the lifetime risk of cardiovascular disease, this has
not been well studied for diabetes. To our knowledge,
this is the first study to examine whether the association
between midlife blood pressure and incidence of type 2
diabetes persists in the general population over an
extended follow-up until old age.
Methods
Study population
Data were derived from the intervention group of the
multifactor Primary Prevention Study, which began in
1970. The study population and design have been
described in detail elsewhere [16]. In brief, all men (n=
approximately 30 000) living in the city of Gothenburg,
Sweden and born between 1915 and 1925 (except those
born in 1923) were randomised into three equally large
groups, where the men in one of the groups (i.e. the
intervention group, n=10 004) were offered a medical
examination to identify and treat risk factors, with the
remaining men randomised into two control groups (i.e.
groups without any interventions) [16]. The intervention
criteria in the study were antihypertensive treatment if
systolic blood pressure (SBP) exceeded 175 mm Hg or
diastolic blood pressure (DBP) 115 mm Hg, dietaryadvice if serum cholesterol levels were above 260 mg per
100 ml (=6.8 mmol-1) and referral to anti-smoking
clinics for participants who smoked 15 cigarettes or
more per day. Treatment was offered at specialist clinics.
During the first 12-year follow-up, there were no signifi-
cant differences in outcomes with respect to cardiovas-
cular disease or all-cause mortality between the
intervention and control groups [16]. Thus, despite the
fact that the men took part in an intervention study, we
consider the study cohort to be representative of the
general Gothenburg male population. All participants
gave their informed consent to participate in the study,
which was approved by the Ethics Committee for Med-
ical Research at the University of Gothenburg.
A total of 7 494 men (75% of the sample) took part in
the baseline screening examination which took place be-
tween January 1970 and March 1973. All participants
completed a postal questionnaire before the examin-
ation. Of the men who took part in the baseline screen-
ing, 149 men had a prior history of diabetes and were
excluded from the analyses. Prior history of diabetes at
baseline was based on participants’ self-reports of diag-
nosed diabetes indicated by the answer ‘yes’ to the ques-
tion ‘Has a physician ever told you that you have
diabetes?’ Participants with missing information on SBP
were also excluded from the analysis (12 cases). The
remaining 7 333 men constitute the basis of the present
study and were followed up for a maximum period of 35
years.
Measurements and definitions
For the purpose of the present study, information
selected from the baseline postal questionnaire included
smoking habits, leisure time physical activity, antihyper-
tensive treatment (yes/no) and occupation. Smoking
habit was divided into never smokers and former smo-
kers of more than 1 month’s duration or current daily
smokers. Physical activity was divided into low (seden-
tary), moderate and regular exercise. Occupation was
classified according to the Swedish socioeconomic classi-
fication system (SEI) and defined as either manual (SEI
1–3 or unclassified) or non-manual (SEI 4–5) [17].
The baseline screening examinations were performed
in the afternoon between 4.00 pm and 7.00 pm after a
working day. Weight was measured to the nearest 0.10
kg and height to the nearest 0.01 metre. Body mass
index (BMI) (weight in kilograms divided by measured
height in square metres) was categorised as <25 (nor-
mal), 25–30 (overweight) and >30 kg/m2 (obese). Serum
cholesterol concentration was determined according to
standard laboratory procedures. Blood pressure was
taken from the right arm with the participant seated,
after a 4–5 minute rest and by physicians trained to
carry out the process repeatedly in a similar manner. A
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nearest 2 mm Hg. A large proportion of the participants
were found to have high blood pressure. In a random
subsample (n=84/2180) blood pressure was also mea-
sured in the morning two weeks later. Mean SBP was
then 7.6 mm Hg lower and mean DBP 8.9 mm Hg lower
in comparison to the screening blood pressure. Among
those with the highest blood pressure levels during the
screening, the mean SBP and DBP was even lower two
weeks later; 16.1 mm Hg and 18.0 mm Hg respectively.
The conclusion made by the original investigators of the
Primary Prevention Study was that the circumstances of
the blood pressure measurements probably influenced the
values and that there was no reason to believe that blood
pressure levels were substantially higher in Gothenburg
than in other populations at that time [18]. Missing data on
all covariates was 1.3% or below.Ascertainment of diabetes incidence
All participants were followed from the date of their
baseline examination until 31 December 2008 using
their unique personal identification number. A computer
file of the study cohort was run against the Swedish na-
tional register on cause of death and the Swedish hos-
pital discharge register. This procedure was reviewed
and approved by the Ethics Committee.
The hospital discharge register has operated on a
nationwide basis since 1987, but all discharges from
Gothenburg hospitals have been entered in the national
register since 1970 (except 1976 owing to a legislative
change for that single year). Type 2 diabetes was identi-
fied from the hospital discharge as a primary or a
secondary diagnosis using a code of 250 (International
Classification of Diseases, Eighth revision [ICD 8], 250
(International Classification of Diseases, Ninth revision
[ICD 9]) or E10-E14 (International Classification of Dis-
eases, 10th revision [ICD 10]). A death certificate diag-
nosis of diabetes as an underlying cause by any of the
diagnostic codes above in a man with no prior diabetes
diagnosis was also accepted. Of the men, only a very
small minority 5.8% (428/7333) had never been hospita-
lised before the end of the follow-up. At 31 December
2008, 98.2% (7 198/7333) of the participants had a regis-
tration in either the Swedish national register of cause of
death or the Swedish hospital discharge register.Classification of blood pressure levels
The blood pressure categories are based on the WHO-
ISH definition [19] where SBP is classified into following
four categories: < 130 (normal), 130–139 (high-normal),
140–159 (mild hypertension) and ≥160 (moderate and
severe hypertension) mm Hg; and DBP into following
three categories: <85 (normal), 85–89 (high-normal), ≥90(hypertension) mm Hg. We regarded SBP and DBP as in-
dependent risk factors and analysed them separately.
Statistics
Descriptive statistics are presented in terms of frequen-
cies and percentages for categorical variables and in
terms of mean with standard deviation for continuous
variables. Differences in the distribution of baseline
characteristics across the blood pressure categories were
examined by chi-square trend test for categorical vari-
ables and by Spearman correlation test for continuous
variables. All p-values are 2-sided and values <0.05 are
considered statistically significant. We calculated age-
adjusted diabetes incidence rates per 100 000 person
years for each blood pressure category. Time at risk was
calculated from the baseline examination between Janu-
ary 1970 and March 1973 to first hospitalisation with a
diagnosis of diabetes (as a principal or a secondary diag-
nosis), to death or to 31 December 2008. Cox propor-
tional hazard models were used to analyse time at risk
and the association with blood pressure levels. In the
blood pressure categories the lowest blood pressure
group was used as the reference. Estimates from the Cox
proportional hazard models are presented as hazard
ratio (HR) and 95% confidence intervals (95% CI). Three
models were used; first we computed the age adjusted
HR, then the age and BMI adjusted HR and finally the
multiple adjusted HR where we adjusted for age, BMI,
cholesterol level, use of antihypertensive treatment,
smoking, physical activity and occupational class. The
assumption of the proportional hazard was tested and
holds for our model. In order to investigate the possible
impact of residual confounding, we have performed sen-
sitivity analyses using Cox proportional hazard models
and calculated the age and multiple adjusted hazard
ratios of diabetes for different blood pressure categories
in different BMI and smoking groups. Due to the long
follow-up and the age of the participants at study entry,
a large proportion, 75% (5644/7494), had died by the
end of the study. In order to take into account death
from other causes we present curves based on the cu-
mulative risk of diabetes adjusted for age and competing
risk of death over the follow-up period according to
levels of blood pressure at baseline. All analyses were
performed using SAS software version 9.2 (SAS institute,
Cary, NC, USA) and Statistical package R2.15 version.
Results
The median follow-up time in our study was 28 years.
The mean age of the study subjects at baseline was 51.6
years (standard deviation (SD) 2.3), the mean SBP was 149
(SD 22) and the mean DBP was 95 (SD 13) mm Hg. After
10 years of follow-up, 1.3% (96/7333) of the men were dis-
charged from hospital with a principal or secondary
Stahl et al. BMC Cardiovascular Disorders 2012, 12:89 Page 4 of 8
http://www.biomedcentral.com/1471-2261/12/89diagnosis of diabetes or were diagnosed as having diabetes
on their death certificate. After 35 years of follow-up the
proportion, without adjustment for competing risk of
death, was 13.0% (956/7333) and the crude incidence of
diabetes was 509 per 100 000 person years. Of the 956
diabetes cases, 54 were from death certificates and thus
902 from hospital discharge registers.
Baseline characteristics for participants in the different
SBP groups are shown in Table 1. The proportion of
men in the SBP groups <130 mm Hg, 130–139 mm Hg,
140–159 mm Hg, and ≥160 mm Hg were 17%, 18%,
36%, and 29% respectively. Participants in the higher
SBP groups were slightly older, had higher BMI and
cholesterol levels, were more likely to use antihyperten-
sive medication, less likely to be physically active,
current smokers or from the non-manual occupational
class than participants in the lower blood pressure
groups.
Table 2 presents age, BMI and multivariable adjusted
HRs for diabetes by different blood pressure categories.
The highest risk was in the highest SBP category where
multivariable adjusted HR for incident diabetes wasTable 1 Baseline characteristics according to systolic blood p
All <130 mm Hg
Characteristics N = 7 333 (n = 1278)
Age, years, mean (SD) 51.6 51.2
(2.3) (2.3)
Body Mass Index kg/m2, mean (SD) 25.5 24.4
(3.2) (2.9)
Obesity. BMI ≥30, % (n) 8.1 3.4
(597) (43)
Diastolic blood pressure, mm Hg, mean (SD) 95 82
(13) (8)
Hypertension treatment, % (n) 5.4 0.7
(396) (9)
Serum cholesterol mmol/L, mean (SD) 6.46 6.22
(1.15) (1.08)
Never smokers, % (n) 29.5 27.2
(2152) (347)
Former smokers, % (n) 20.4 19.0
(1493) (242)
Current smokers, % (n) 50.1 53.8
(3660) (686)
Physically active, % (n) 16.0 18.3
(1156) (232)
Non-manual occupation 27.9 31.2
(2044) (399)
SD = standard deviation. BMI=Body Mass Index. *P-values calculated by chi-square
continuous variables.1.95 (95% CI 1.55-2.46) in men with SBP ≥160 mm Hg
compared to SBP <130 mm Hg (referent). The HRs
were also significantly higher in the two lower SBP cat-
egories, including the high-normal category of 130 to
139 mm Hg, and to approximately the same extent.
The inclusion of BMI reduced the estimates signifi-
cantly more than any other variable, taken separately or
together. The multiple adjusted HR for diabetes was
1.34 (95% CI 1.12-1.62) in men with DBP ≥90 mm Hg
compared to DBP below 85 mm Hg (referent). In the
DBP category 85 to 89 mm Hg there was no signifi-
cantly increased risk compared to DBP below 85 mm
Hg.
We have also calculated the multivariable adjusted
HRs for diabetes by SBP categories in different BMI
and smoking categories. The effect of increasing
blood pressure on risk of diabetes was similar irre-
spective of BMI category or smoking status, with no
suggestion of an interaction effect (Additional file 1:
Table S3).
Figure 1 presents the cumulative risk of diabetes over
time adjusted for age and competing risk of death inressure categories
Systolic blood pressure categories
130-139 mm Hg 140-159 mm Hg ≥160 mm Hg
(n = 1315) (n = 2623) (n = 2117) p-values*
51.3 51.6 51.9 <0.0001
(2.4) (2.3) (2.1)
25.2 25.6 26.3 <0.0001
(2.9) (3.2) (3.5)
5.6 8.2 12.6 <0.0001
(73) (214) (267)
88 94 107 <0.0001
(8) (8) (12)
0.7 3.2 13.8 <0.0001
(9) (85) (293)
6.47 6.47 6.61 <0.0001
(1.10) (1.17) (1.18)
27.1 29.7 32.0 0.0004
(355) (775) (675
20.9 21.3 20.0 0.68
(273) (555) (423)
52.0 49.0 48.0 0.0004
(681) (1279) (1014)
17.6 16.1 13.5 <0.0001
(228) (414) (282)
29.4 27.8 25.1 <0.0001
(386) (728) (531)
trend test for categorical variables and by Spearman correlation test for






















< 130 mm Hg (normal) 1 279 109 36292 300 ref. ref. ref.
130 – 139 mm Hg
(high-normal)
1 315 159 35541 447 1.56 (1.22-1.99) 1.39 (1.09-1.78) 1.43 (1.12-1.84)
140 – 159 mm Hg
(mild hypertension)
2622 330 69845 472 1.66 (1.34-2.07) 1.40 (1.13-1.75) 1.43 (1.14-1.79)
≥ 160 mm Hg
(moderate/severe)
2117 358 51695 693 2.68 (2.16-3.32) 2.03 (1.63-2.52) 1.95 (1.55-2.46)
Increase per 10 mm Hg 1.16 (1.13-1.18) 1.12 (1.08-1.14) 1.10 (1.07-1.14)
Diastolic blood pressure
< 85 mm Hg (normal) 1628 157 45528 345 ref. ref. ref.
85 – 89 mm Hg (high normal) 896 83 24227 343 1.02 (0.78-1.33) 0.95 (0.72-1.23) 0.93 (0.70-1.22)
≥ 90 mm Hg (hypertension) 4809 716 123617 579 1.82 (1.53-2.16) 1.41 (1.18-1.68) 1.34 (1.12-1.62)
Increase per 5 mm Hg 1.14 (1.12-1.17) 1.09 (1.06-1.11) 1.08 (1.06-1.11)
*Multivariable adjusted model included age, body mass index, cholesterol level, antihypertensive treatment, smoking, physical activity and occupational class.
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betes in the SBP groups <130 mm Hg, 130–139 mm Hg,
140–159 mm Hg and ≥160 mm Hg was considerably
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Figure 1 Cumulative risk of diabetes by different systolic blood press
competing risk of death over the 35-year follow-up based on the level of S
mm Hg and ≥160 mm Hg).Discussion
In this prospective study of middle-aged men who were
followed for 35 years or until death, we found that even
moderately increased SBP predicted the subsequent de-





ure categories. Cumulative risk of diabetes adjusted for age and
BP at baseline (SBP levels: <130 mm Hg, 130–139 mm Hg, 140–159
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potential confounders, with the greatest risk of subse-
quent development of diabetes in the highest blood pres-
sure group. The finding that blood pressure within the
higher normal blood pressure range increases the risk of
diabetes is consistent with the findings from earlier stud-
ies [9-13], with the added information that the increased
risk remains through an extended follow-up until old
age. Our median follow-up was 28 years which is consid-
erably longer than in previous studies which were 8.9 [9],
7.8 [10], 10.2 [11], 12.5 [12] or a mean follow-up of 8.3
±1.0 [13] years. Findings for DBP were similar, albeit less
pronounced, with only DBP above 90 mm Hg indicating
a later risk of diabetes. This is consistent with some stud-
ies [20] which did not find DBP to be a risk factor for in-
cident diabetes whereas other studies did [7].
Compared to other studies [9-13] we have a low pro-
portion of diabetes cases during the first 10 years and
this is probably explained by the fact that diabetes is
often managed in primary care during the first years
after diagnosis. We have a detection delay in the study
since we did not have access to primary care data and
were able to identify diabetes only as a hospital dis-
charge diagnosis.
We found an inverse relation between smoking and
blood pressure, probably due to the fact that smokers
weigh less, which has also been described elsewhere
[21]. Body weight is a strong determinant for diabetes.
The increased risk of diabetes in the higher blood
pressure categories was strongly attenuated when
adjusting for BMI. This is in coherence with what
other studies have found [9,13] and indicates that BMI
is the factor with the greatest influence on diabetes
risk.
At baseline the participants were asked about antihy-
pertensive medication and the analyses were adjusted for
this. Data on new antihypertensive treatment during
follow-up was not available. This could be a bias since
some antihypertensive drugs are known to increase the
risk of developing diabetes [22]. Other studies have indi-
cated that the greatest increase in risk of later develop-
ment of type 2 diabetes in a hypertensive patient is due to
hypertension itself [8] and that the increased risk of dia-
betes remains after adjusting for specific antihypertensive
treatments [23]. Therefore it does not seem plausible that
medication could explain more than part of the total
effect.
The benefits of considering high-normal blood pres-
sures as a predisease have been debated [24]. Whether
this should be labeled predisease or not may not be the
issue here, however, but what this and other studies [10-
13] show is that the risk of developing diabetes is already
increased at blood pressure levels below the limits gen-
erally used in considering treatment for hypertension.The clinical impact of these findings should be further
analysed in appropriate studies.
The pathophysiological mechanisms underlying the as-
sociation between high blood pressure and type 2 dia-
betes are not yet completely identified. Hypertension has
been shown to induce microvascular changes [25] and
these changes may result in a reduced capacity for insu-
lin mediated glucose uptake in the tissue [26]. Impaired
microcirculation in tissues may thus be the connecting
link between hypertension and insulin resistance [27].
Microcirculation has also been shown to be impaired by
obesity; microcirculation has therefore emerged as a po-
tential common denominator for several risk factors for
metabolic syndrome [28,29]. Hypertension is also asso-
ciated with endothelial dysfunction [30] and markers of
endothelial dysfunction have in turn been demonstrated
to precede the development of diabetes [31]. Another
possible linking factor between blood pressure and dia-
betes is inflammation. Hypertension [32] and diabetes
[33] are both known to be associated with an increase in
inflammatory markers.
Strengths and limitations
The strengths of the present study include a large num-
ber of unselected participants from the general popula-
tion, prospective longitudinal design, extended follow-
up, and hence the identification of a large number of
diabetes cases (956 cases or 13%) compared to other
studies [10-13]. Even so, there are also a number of lim-
itations to be considered. Firstly, participants who
reported no history of diabetes during the screening
examination were considered to be free from diabetes
but neither blood glucose analyses nor an oral glucose
tolerance test were performed. Therefore some of the par-
ticipants might have had undiagnosed diabetes at inclu-
sion. However, the majority of diabetes cases were
identified at least a decade after the screening, so it is un-
likely that the few cases that might have been included
could significantly affect our results. We have also per-
formed an analysis in which all the diabetes cases that are
identified during the first 7.5 years were excluded which
did not alter our results. Secondly, diabetes was defined
as a discharge from hospital with a primary or secondary
diagnosis code or a death certificate diagnosis of diabetes
as an underlying cause. Some of the participants who
developed diabetes but did not visit hospital during the
follow-up period might not have been identified. Even so,
the majority of them did attend hospital at some point
(94.2%) and most of them several times, particularly in
the last few years of the follow-up. Additionally, in our re-
search group we have carefully followed another cohort
of men, the men born in 1913 in Gothenburg, for whom
we also have data from primary health care centres as
well as diagnosis data from the registers. After 30 years of
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betes (unpublished data) which is a similar figure to the
proportion of men who developed diabetes in the Primary
Prevention Study. Therefore, we believe that most of the
diabetes cases were actually detected in the current ana-
lyses. Thirdly, the older ICD versions (ICD 8 and ICD 9)
do not distinguish between type 1 and type 2 diabetes;
however, given the age of the population, few, if any cases
would have been type 1 diabetes. Fourthly, a remaining
issue could be whether people reacting with high blood
pressure at the screening were more prone to develop
diabetes. This is something we are unable to adjust for in
the study and, as we see it, a separate issue that must be
analysed in another study. Fifthly, information on import-
ant risk factors other than blood pressure may be consid-
ered to be somewhat crude; therefore our results might
have been affected by residual confounding. For instance,
we have only information about BMI and not hip-waist
ratio. One study investigating the relationship between
blood pressure and diabetes incidence [13] had both BMI
and hip-waist measurement and there was a very minor
difference in diabetes risk when using BMI instead of hip-
waist ratio. For physical activity, no figures for hours per
week are available in our study, just classification into 3
groups (sedentary, moderate and active). In their study,
Conen et al. [11] had information regarding the number
of hours per week of physical activity, and even after con-
trolling for this, the relationship between blood pressure
and diabetes remained. In our study no information on
smoking duration is available, and nor do we have dietary
information. Diet pattern has been shown to affect dia-
betes incidence in a previous study [34] but to our know-
ledge there are no studies concerning the relationship
between blood pressure and diabetes that have adjusted
for dietary pattern. Nevertheless, it seems unlikely that in-
formation about smoking duration and dietary pattern
would eliminate the significance in our findings. Moreover,
the results from our sensitivity analysis showed that the
problem of residual confounding is likely to be negligible.
Finally, we have only baseline information on all of the
covariates. Many of the covariates are time dependent and
fluctuations occur. Therefore we might not have captured
the total influence of the covariates on the association be-
tween blood pressure levels and diabetes incidence.
Conclusion
In conclusion, the present study has shown that hyper-
tension and high-normal systolic blood pressure at mid
life is a significant risk factor for type 2 diabetes in men
over a 35-year follow-up period. The association be-
tween blood pressure and type 2 diabetes was independ-
ent of BMI and other conventional risk factors. Even so,
further studies are needed to assess clinical impact of
these findings and whether physicians should considerhigh-normal blood pressure patients for intense diabetes
screening.Additional file
Additional file 1: Table S3. a. Hazard ratio for diabetes by systolic
blood pressure (SBP) categories in different BMI categories. b; Hazard
ratio for diabetes by systolic blood pressure (SBP) categories in different
smoking categories.
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